Skip to main content

Table 2 Factor analysis

From: Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)

Items Factor loading
Factor 1 Factor 2 Factor 3
1. Missed dose 0.549 − 0.166 0.149
2. Difficulty swallowing 0.099 0.272 0.161
3. Carrying and preparing for taking the agent 0.589 0.034 0.158
4. People around the patient 0.347 − 0.015 0.218
5. Following the meal schedule 0.819 0.058 − 0.145
6. Interval between taking the agent and a meal 0.933 − 0.034 − 0.140
7. Compliance with treatment schedule 0.885 0.008 − 0.088
8. Number of doses 0.660 0.048 0.119
9. Taking the agent at a place other than home 0.507 0.101 0.187
10. Desire to continue the treatment 0.213 − 0.044 0.562
11. Rumbling stomach 0.297 0.302 0.031
12. Diarrhea 0.142 0.430 0.014
13. Constipation − 0.066 0.634 − 0.078
14. Increase in body weight − 0.159 0.374 0.109
15. Tendency to become hungry easily 0.068 0.497 0.104
16. Nausea 0.110 0.529 − 0.040
17. Bodily swelling 0.041 0.599 − 0.103
18. Hypoglycemia − 0.070 0.382 0.187
19. Frequent urination 0.117 0.317 0.172
20. Thirst 0.116 0.435 0.170
21. Discomfort with urination or genital pruritus − 0.031 0.503 0.030
22. Glycemic control − 0.133 0.105 0.542
23. Satisfaction with the current agent 0.128 0.035 0.735
  1. The principal factor method with three-factor promax rotation was applied; n = 188; Values of factor loadings attributed subscale are shown in italics